Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1963 1
1964 2
1968 1
1974 1
1975 3
1976 3
1977 9
1978 6
1979 12
1980 14
1981 12
1982 17
1983 18
1984 20
1985 38
1986 42
1987 46
1988 76
1989 129
1990 194
1991 251
1992 273
1993 293
1994 328
1995 310
1996 349
1997 354
1998 342
1999 328
2000 301
2001 346
2002 359
2003 328
2004 364
2005 444
2006 453
2007 511
2008 535
2009 472
2010 543
2011 553
2012 531
2013 571
2014 518
2015 472
2016 518
2017 474
2018 479
2019 493
2020 521
2021 522
2022 439
2023 398
2024 410
2025 453
2026 193

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,287 results

Results by year

Filters applied: . Clear all
Page 1
EPO and EPO-Receptor System as Potential Actionable Mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP.
Auzmendi J, Puchulu MB, Rodríguez JCG, Balaszczuk AM, Lazarowski A, Merelli A. Auzmendi J, et al. Curr Pharm Des. 2020;26(12):1356-1364. doi: 10.2174/1381612826666200219095548. Curr Pharm Des. 2020. PMID: 32072891 Review.
EPO low levels are found in the central nervous system (CNS), while EPO-R is expressed in most CNS cell types. ...In the heart, high EPO-R expression in cardiac progenitor cells appears to contribute to myocardial regeneration under EPO stimulation. ..
EPO low levels are found in the central nervous system (CNS), while EPO-R is expressed in most CNS cell types. ...In the heart
Epo-C12 inhibits peroxiredoxin 1 peroxidase activity.
Yoda T, Furuta M, Tsutsumi T, Ikeda S, Yukizawa S, Arai S, Morita A, Yamatoya K, Nakata K, Tomoshige S, Ohgane K, Furuyama Y, Sakaguchi K, Sugawara F, Kobayashi S, Ikekita M, Kuramochi K. Yoda T, et al. Bioorg Med Chem. 2021 Jul 1;41:116203. doi: 10.1016/j.bmc.2021.116203. Epub 2021 May 10. Bioorg Med Chem. 2021. PMID: 34015702
Epo-C12 induces apoptosis in human acute lymphoblastoid leukemia BALL-1 cells. In our previous studies, seven proteins that bind to Epo-C12 were identified by a combination of pull-down experiments using biotinylated Epo-C12 (Bio-Epo-C12) and mass spec
Epo-C12 induces apoptosis in human acute lymphoblastoid leukemia BALL-1 cells. In our previous studies, seven proteins that bind to
Nonrenal regulation of EPO synthesis.
Weidemann A, Johnson RS. Weidemann A, et al. Kidney Int. 2009 Apr;75(7):682-8. doi: 10.1038/ki.2008.687. Epub 2009 Jan 21. Kidney Int. 2009. PMID: 19165176 Free article. Review.
Tissue-specific expression of the EPO gene is tightly controlled, and in the adult organism the kidney produces around 90% of systemic EPO. ...Apart from classical ways of regulating renal EPO during hypoxia and anemia, novel pathways have been discovered tha …
Tissue-specific expression of the EPO gene is tightly controlled, and in the adult organism the kidney produces around 90% of systemi …
EPO-modified bone marrow MSCs alleviate asthma inflammation through enhanced mitochondrial activation and transfer by upregulating HO-1.
Zhang Y, Chen LZ, Ou-Yang HF. Zhang Y, et al. Mol Med. 2025 Sep 29;31(1):307. doi: 10.1186/s10020-025-01371-7. Mol Med. 2025. PMID: 41023810 Free PMC article.
Our previous study has highlighted the ability of erythropoietin (EPO)-modified BM-MSCs (EPO-BM-MSCs) to relieve asthmatic inflammation. Here, we elucidated whether EPO-BM-MSCs improve asthmatic phenotype by mitochondrial transfer and investigated the underly …
Our previous study has highlighted the ability of erythropoietin (EPO)-modified BM-MSCs (EPO-BM-MSCs) to relieve asthmatic inf …
Rational design of selective bispecific EPO-R/CD131 agonists.
Doiron KE, Way JC, Silver PA. Doiron KE, et al. Protein Eng Des Sel. 2025 Jan 10;38:gzaf013. doi: 10.1093/protein/gzaf013. Protein Eng Des Sel. 2025. PMID: 41206499
Erythropoietin (EPO) suppresses apoptosis and promotes survival by signaling through EPO-R/EPO-R on hematopoietic progenitors or EPO-R/CD131 on non-hematopoietic cells. ...Here, we constructed a structural model of EPO-R/CD131 and designed sever …
Erythropoietin (EPO) suppresses apoptosis and promotes survival by signaling through EPO-R/EPO-R on hematopoietic proge …
Rational design of selective bispecific EPO-R/CD131 agonists.
Doiron KE, Way JC, Silver PA. Doiron KE, et al. bioRxiv [Preprint]. 2025 Aug 26:2025.04.10.648227. doi: 10.1101/2025.04.10.648227. bioRxiv. 2025. Update in: Protein Eng Des Sel. 2025 Jan 10;38:gzaf013. doi: 10.1093/protein/gzaf013. PMID: 40909672 Free PMC article. Updated. Preprint.
Erythropoietin (EPO) suppresses apoptosis and promotes survival by signaling through EPO-R/EPO-R on hematopoietic progenitors or EPO-R/CD131 on non-hematopoietic cells. ...Here, we constructed a structural model of EPO-R/CD131 and designed sever …
Erythropoietin (EPO) suppresses apoptosis and promotes survival by signaling through EPO-R/EPO-R on hematopoietic proge …
Rethinking EPO: A Paradigm Shift in Oncology?
Ferrero JM, Mograbi B, Bouriga R, Gal J, Milano G. Ferrero JM, et al. Cancers (Basel). 2025 Dec 3;17(23):3875. doi: 10.3390/cancers17233875. Cancers (Basel). 2025. PMID: 41375075 Free PMC article.
Erythropoietin (EPO) is a hormone mainly produced by the kidney. EPO stimulates red blood cell production in response to hypoxia. ...Yet, accumulating scientific evidence knowledge has highlighted the complex interactions between EPO and tumor biology that ex …
Erythropoietin (EPO) is a hormone mainly produced by the kidney. EPO stimulates red blood cell production in response to hypox …
Are current methods of measurement of erythropoietin (EPO) in human plasma or serum adequate for the diagnosis of polycythaemia vera and the assessment of EPO deficiency?
Lindstedt G, Lundberg PA. Lindstedt G, et al. Scand J Clin Lab Invest. 1998 Oct;58(6):441-58. doi: 10.1080/00365519850186247. Scand J Clin Lab Invest. 1998. PMID: 9832336 Review.
Current methodology for the immunoassay of erythropoietin (EPO) in human plasma or serum is reviewed, with an emphasis on measurement of EPO concentrations in the low and normal ranges, analytical interference and blood sampling requirements. ...It is concluded that …
Current methodology for the immunoassay of erythropoietin (EPO) in human plasma or serum is reviewed, with an emphasis on measurement …
To give or not to give recombinant EPO to anemia endangered cancer patients.
Sulkowska M, Wincewicz A, Chabowska A, Kanczuga-Koda L, Szymanska M, Koda M, Witkowska E, Sulkowski S. Sulkowska M, et al. Prague Med Rep. 2006;107(3):281-9. Prague Med Rep. 2006. PMID: 17385400 Review.
The main task concerning EPO for oncologists is the choice to give or not to give recombinant EPO to anemia endangered cancer patients. ...Nevertheless, EPO therapy shortens survival of patients in some cancers, in which antiapoptotic effect of EPO pre …
The main task concerning EPO for oncologists is the choice to give or not to give recombinant EPO to anemia endangered cancer …
Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events.
van Rijt WG, van Goor H, Ploeg RJ, Leuvenink HG. van Rijt WG, et al. Transpl Int. 2014 Mar;27(3):241-8. doi: 10.1111/tri.12174. Epub 2013 Aug 22. Transpl Int. 2014. PMID: 23964738 Free article. Review.
In preclinical models, nonerythropoietic EPO derivatives, such as carbamoylated EPO and ARA290, have been tested. These EPO derivatives improve renal function and do not affect erythropoiesis. Therefore, nonerythropoietic EPO derivatives may be able to …
In preclinical models, nonerythropoietic EPO derivatives, such as carbamoylated EPO and ARA290, have been tested. These EPO
14,287 results
You have reached the last available page of results. Please see the User Guide for more information.